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Abstract
Background: Many studies in the vertebrate retina have characterized the differentiation of
amacrine cells as a homogenous class of neurons, but little is known about the genes and factors
that regulate the development of distinct types of amacrine cells. Accordingly, the purpose of this
study was to characterize the development of the cholinergic amacrine cells and identify factors
that influence their development. Cholinergic amacrine cells in the embryonic chick retina were
identified by using antibodies to choline acetyltransferase (ChAT).
Results:  We found that as ChAT-immunoreactive cells differentiate they expressed the
homeodomain transcription factors Pax6 and Islet1, and the cell-cycle inhibitor p27kip1. As
differentiation proceeds, type-II cholinergic cells, displaced to the ganglion cell layer, transiently
expressed high levels of cellular retinoic acid binding protein (CRABP) and neurofilament, while
type-I cells in the inner nuclear layer did not. Although there is a 1:1 ratio of type-I to type-II cells
in vivo, in dissociated cell cultures the type-I cells (ChAT-positive and CRABP-negative) out-
numbered the type-II cells (ChAT and CRABP-positive cells) by 2:1. The relative abundance of type-
I to type-II cells was not influenced by Sonic Hedgehog (Shh), but was affected by compounds that
act at muscarinic acetylcholine receptors. In addition, the abundance and mosaic patterning of type-
II cholinergic amacrine cells is disrupted by interfering with muscarinic signaling.
Conclusion: We conclude that: (1) during development type-I and type-II cholinergic amacrine
cells are not homotypic, (2) the phenotypic differences between these subtypes of cells is
controlled by the local microenvironment, and (3) appropriate levels of muscarinic signaling
between the cholinergic amacrine cells are required for proper mosaic patterning.
Background
Amacrine cells are a distinct class of retinal neuron that
participate in the processing and refinement of visual
information. The amacrine cells receive input from other
amacrine cells and bipolar cells, release inhibitory neuro-
transmitters (GABA and/or glycine) at synapses that are
formed with ganglion cells and other amacrine cells, and
participate in retinal image processing. Amacrine cells are
a highly diverse class of neuron; there may be as many as
30 distinct types [1,2]. The classical findings of Cajál [3]
and additional work [4-14] suggest that there may be as
many as 30 different types of amacrine cells in the avian
retina. Although many studies have identified mecha-
nisms that promote or suppress amacrine cell fate, little is
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known about the mechanisms involved in the differentia-
tion of specific types of amacrine cells. The factors that
instruct cells from a pool of amacrine-fated neurons to
form particular types of amacrine cells remain largely
unknown. In this study we use the cholinergic cells in the
embryonic chick retina as a model system to study the
mechanisms involved in the differentiation of one partic-
ular type of amacrine cell.
Cholinergic neurons use acetylcholine (ACh) as a trans-
mitter and are found in the retina of all vertebrate classes.
Cholinergic amacrine cells have somata located at the
proximal margin of the inner nuclear layer (INL; type-I)
and displaced to the ganglion cell layer (GCL; type-II)
with processes confined to two strata in the inner plexi-
form layer (IPL) [15-23]. Type-I and type-II cholinergic
amacrine cells are arrayed in a mosaic pattern with near-
mirror symmetry around a horizontal plane through the
IPL [18,19]. However, the patterned spacing of cells
within one layer is independent of the spacing of the cells
in the other layer [24]. The retinas of birds and reptiles
contain a third type of cholinergic amacrine cell, with
somata located near the middle of the INL and processes
diffusely distributed in sub-laminae 1 through 4 of the IPL
[21]. Furthermore, avian type-III cholinergic amacrine
cells can be segregated into 2 subtypes: type-IIIa cells that
contain enkephalin, neurotensin, and somatostatin
immunoreactivities, and type-IIIb cells that do not [4].
During embryonic development, type-I and type-II
cholinergic amacrine cells express ChAT (the biosynthetic
enzyme that produces ACh) as early as embryonic day 6.5
(E6.5), whereas ChAT-immunoreactivity in type-III cells is
not detected until 6 days prior to hatching at about E15
[23]. Cholinergic amacrine cells arise from a pool of
undifferentiated post-mitotic neuronal cells and begin to
differentiate in the middle of the presumptive IPL where
they, coincidently, accumulate GABA [23,25]. Although a
great deal is known about the morphological and tempo-
ral development of these amacrine cells, little is known
about the genes that they express during differentiation
and the factors that influence their development. How-
ever, it has recently been shown that extra-cellular ATP
and the P2X receptor coordinate, in part, the mosaic pat-
terning and survival of the cholinergic cells in the rodent
retina [26] and that visual activity is required for mainte-
nance of the mosaic after eye opening in the mouse [27].
The purpose of this study was to better characterize the
development of type-I and type-II cholinergic amacrine
cells in the chick retina and identify factors that influence
their development. We find that the type-I and type-II
cholinergic amacrine cells express p27kip1, Pax6 and Islet1
during development. In addition, we show that these cells
are not homotypic during embryonic development; type-
II cells transiently express elevated levels of cellular retin-
oic acid binding protein (CRABP) and neurofilament,
while type-I cells do not. Furthermore, we show that the
relative abundance of type-I and type-II cholinergic cells is
influenced by local microenvironment and signalling
through muscarinic acetylcholine receptors. We propose
that autologous signalling between cells acts to drive the
differentiation and mosaic patterning of distinct types of
retinal amacrine cells.
Results
Cholinergic amacrine cells in the embryonic chick retina
were detected by using antibodies to choline acetyltrans-
ferase (ChAT). ChAT-immunoreactive amacrine cells were
first detected in the retina at embryonic day 6 (E6; Fig.
1c–e), consistent with a previous report [23]. One day
later at E7, in central regions of the retina, these cells
formed two uniform rows of cells, with type-I cells located
at the distal border of the presumptive IPL and type-II cells
located within the proximal half of the presumptive IPL
(Fig. 1g), similar to previous findings [23,25].
Cholinergic amacrine cells express Islet1 and Pax6 as they 
differentiate
In the developing rodent retina, cholinergic amacrine cells
are known to express Islet1 [28]. Islet1 is a homeotic LIM-
domain transcription factor that is known to be expressed
by bipolar, horizontal, and ganglion cells in the retina
[29]. In the developing avian retina at E6, Islet1-immuno-
reactivity was detected in the nuclei of presumptive gan-
glion and amacrine cells in the GCL and in differentiating
cells in the distal retina (Figs. 1a and 1b). The Islet1-posi-
tive nuclei in the distal retina presumably were post-
mitotic neurons migrating away from the ventricular sur-
face of the retina to their final position within the retina.
At E6, Islet1 was expressed by ChAT-immunoreactive cells
prior to the formation of the presumptive IPL (Figs. 1c–e).
These cells were intermingled with Islet1-expressing cells
in the GCL, suggesting that the cholinergic cells begin to
differentiate among a heterogeneous pool of post-mitotic
Islet1+/ChAT- cells. At E7, Islet1-positive nuclei were
found in the GCL, putative differentiating bipolar cells in
distal layers (not shown) of the retina, and two rows of
cells between the GCL and bipolar cells (Figs. 1f–h). The
Islet1-positive nuclei at the vitread border of the INL and
within the IPL were those of type-I and type-II cholinergic
amacrine cells, respectively (Figs. 1f–h). At E9 and E11,
the Islet1/ChAT-positive cells remained as distinctive
rows of cells (Figs. 1i–n). By E16 the somata of the type-II
cells had migrated into the GCL. In the retina of postnatal
chickens, Islet1-immunoreactivity was present in horizon-
tal cells, many bipolar cells, most if not all ganglion cells,
and type-I and type-II cholinergic amacrine cells, but not
type-III cells (Fig. 1o).BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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Type-I and type-II cholinergic amacrine cells express Islet1 throughout embryonic development, whereas type-III cells do not Figure 1
Type-I and type-II cholinergic amacrine cells express Islet1 throughout embryonic development, whereas type-III cells do not. 
Vertical sections of chick retina labeled with antibodies to Islet1 (green) and ChAT (red). Tissues were obtained from chicks at 
E6 (a-e), E7 (f-h), E9 (i-k), E11 (l-n), and P7 (o). Arrows indicate cells that are labeled for ChAT and Islet1, and arrow-heads 
indicate type-III cells that are immunoreactive for ChAT alone. The calibration bar (50 μm) in panel k applies to panels a, b, f-
k and o, and the bar in n applies to panels c-e and l-n. Abbreviations: ChAT – choline acetyltransferase; INL – inner nuclear 
layer; IPL – inner plexiform layer; GCL – ganglion cell layer.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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To test whether homeodomain transcription factors in
addition to Islet1 are expressed by developing cholinergic
amacrine cells, we double-labeled sections with antibod-
ies to ChAT and Pax6, AP2?, Prox1 or Brn3b. Pax6 is
paired-class homeodomain transcription factor that is
known to be expressed by neural progenitors in the
embryonic and postnatal chick retina [30-33]. Pax6 is
expressed at low levels in progenitors and becomes
expressed at high levels in amacrine and ganglion cells as
they differentiate [30,31]. We used a monoclonal anti-
body to Pax6 that is known to label horizontal, amacrine,
ganglion cells and progenitors in the avian retina
[29,31,32]. In E7 and E11 retinas, type-I and type-II
cholinergic amacrine cells expressed relatively low levels
of Pax6; Pax6-immunolabeling was more intense in the
nuclei of non-cholinergic neurons in the GCL and INL
compared to the labeling intensity of the nuclei of the
ChAT-immunoreactive cells (Figs. 2a–f). The cholinergic
Cholinergic amacrine cells express low levels of Pax6 and high levels of p27kip1 compared to other amacrine cells Figure 2
Cholinergic amacrine cells express low levels of Pax6 and high levels of p27kip1 compared to other amacrine cells. Vertical sec-
tions of chick retina were labeled with antibodies to Pax6 (green; a, c, d and f) or p27kip1 (green; g, i, j and l) and ChAT (red). 
The tissues were obtained from chicks at E7 (a-c and g-i) and E11 (d-f and j-l). Arrows indicate cholinergic amacrine cells that 
are labeled for Pax6 or p27kip1, and small double arrows indicate p27kip1-negative cells in the progenitor cell layer of the E7 ret-
ina. The calibration bar (50 μm) in panel l applies to all panels. Abbreviations: ChAT – choline acetyltransferase; INL – inner 
nuclear layer; IPL – inner plexiform layer; GCL – ganglion cell layer.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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amacrine cells did not express AP2?, Prox1, or Brn3a dur-
ing embryonic development or in the postnatal retina
(results not shown).
The cell cycle inhibitor p27kip1 has been shown to be
important for the development of the retina and differen-
tiation of Müller glia [34-36]. In E7 retina, immunoreac-
tivity for p27kip1 was seen in numerous nuclei scattered
throughout the retina, but was absent from the nuclei of
proliferating progenitors in distal layers of the retina (Figs.
2g–i). The distribution of p27kip1-immunoreactive nuclei
in E7 retina was consistent with the known location of dif-
ferentiating cells. At this stage of development, immature
ChAT-positive cells contained p27kip1-immunoreactive
nuclei (Figs. 2g–i). At E11, numerous p27kip1-positive
nuclei were observed in the INL, IPL and GCL (Fig. 2j–l).
The p27kip1-positive nuclei in the IPL were immunoreac-
tive for ChAT, and the labeling intensity of these nuclei
was greater than that seen in the nuclei of non-cholinergic
cells of the INL and GCL (Figs. 2j–l).
Cholinergic amacrine cells transiently express 
neurofilament and CRABP as they differentiate
Neurofilament is known to be expressed by ganglion cells
soon after they begin to differentiate, and the ganglion
cells in the chick retina are thought to be the only type of
neuron that expresses this intermediate filament [37]. Sur-
prisingly, we found that the neurites of type-I and type-II
cholinergic amacrine cells were immunoreactive for neu-
rofilament in the retinas from E8 (Figs. 3a–c) through E12
(Figs. 3d–f). Increased levels of neurofilament-immuno-
reactivity were detected in the type-II cholinergic cells,
compared to levels seen in the type-I cells (Fig. 3). At E8,
neurofilament-immunoreactivity was present in a "tuft"
of processes at the distal edge of the type-II cholinergic
amacrine cells, while little or no immunoreactivity was
detected in the type-I cells (Fig. 3a–c). By E12, neurofila-
ment-immunoreactivity was present throughout the neu-
rites of type-II cells, while sparse immunoreactivity was
present in the neurites of type-I cells (Fig. 3d–f). In E18
and postnatal retinas, neurofilament-immunoreactivity
was not present in the cholinergic amacrine cells (Figs.
3g–i).
In the embryonic chick retina, CRABP was expressed by
numerous differentiating amacrine cells (Fig. 4), consist-
ent with a previous report [38]. At E6, CRABP-immunore-
active cells were found near the developing GCL (Fig. 4a)
and a few of these cells were also immunoreactive for
ChAT (Figs. 4a–c). At E7, most of the CRABP-immunore-
active cells were located in the presumptive IPL and these
cells were also immunoreactive for ChAT (presumptive
type-II cholinergic cells) (Figs. 4d–f). Low levels of CRABP
could be detected in a few (7.05%, n = 242) presumptive
type-I cells in the proximal INL (Figs. 4d–f). This finding
indicates that a minority of type-I cells may express low
levels of CRABP during a narrow window of development.
In E8 retina, high levels of CRABP-immunoreactivity were
detected in type-II cholinergic cells located in the proxi-
mal IPL and weak CRABP-immunoreactivity was detected
in non-cholinergic cells as they differentiate in the pre-
sumptive INL (Fig. 4g). The cell bodies of type-I cells con-
tained little or no CRABP-immunoreactivity in the E8
retina. Differential expression of CRABP was most notice-
able at E11, after the cells have extended their neurites
into the IPL. Type-II cells expressed high levels of CRABP
in their cell bodies, as well as neurites, whereas CRABP
was absent from somata of type-I cells and low levels may
have been present in the neurites (Figs. 4j–l). Type-II
cholinergic cells continued to express CRABP as they dif-
ferentiated through E16 (Figs. 4m–o). At E18, 3 days
before hatching, immunoreactivity for CRABP was no
longer detectable in the type-II cholinergic cells (Figs.
4p–r). To better assess whether the dendrites of the
cholinergic cells contained CRABP, high-magnification
confocal images were obtained. In E16 retinas, we
observed significant CRABP-immunoreactivity in the
stratified neurites of the type-II cells. By contrast, CRABP-
immunoreactivity was no longer detectable in the proc-
esses of type-II amacrine cells at P3 (compare Fig. 4o inset
and 4u inset). In postnatal chick retina, CRABP-immuno-
reactivity was not observed in type-II cholinergic cells
(Figs. 4s–u), but was present in non-cholinergic amacrine
cells and bipolar cells, consistent with a previous report
[39]. Taken together, these findings indicate that during
embryonic development the cholinergic cells are not
homotypic. The phenotypic differences between type-I
and type-II cells may occur because of differences
imposed by the local microenvironment. In other words,
the local microenvironment provided by the INL likely
influences the phenotype of type-I cells, whereas the prox-
imal IPL and/or GCL may influence the phenotype of the
type-II cells; a spatial separation of 20 to 30 µm within the
developing retina.
Differentiation of cholinergic amacrine cells in dissociated 
cell cultures
To test whether the microenvironment influences the phe-
notype of type-I and type-II cholinergic amacrine cells, we
dissociated retinas from E7 chick embryos and main-
tained these cells in culture for 3 days. Dissociated cell cul-
tures will not accurately recapitulate the
microenvironment provided in vivo where different cells,
and the cues provided by these cells, are highly spatially
organized into discrete laminae. To discriminate between
type-I and type-II cholinergic amacrine cells we double-
labeled cells with antibodies to ChAT and CRABP. Cells
immunoreactive for ChAT and CRABP (in the cell body)
were counted as type-II cells and cells that were immuno-
reactive for ChAT alone were counted as type-I cells (Figs.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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5a–c). In vivo, numbers of type-I and type-II cholinergic
amacrine cells in the developing retina are approximately
equal (51.2 ± 4.8%). In dissociated cell cultures of embry-
onic retina, however, type-I cholinergic cells are approxi-
mately twice (2.1 ± 0.4; n = 5 culture sets) as abundant as
type-II cells (Figs. 5a, 5b and 5f). The decrease in the rela-
tive abundance of type-II to type-I cells did not change sig-
nificantly with differences in original plating density
Type-II cholinergic amacrine cells transiently express neurofilament during embryonic development Figure 3
Type-II cholinergic amacrine cells transiently express neurofilament during embryonic development. Vertical sections of chick 
retina labeled with antibodies to neurofilament (green) and ChAT (red). Sections were obtained from embryos at E8 (a-c) E11 
(d-f), or from a postnatal chick (P2) (g-i). The boxed-out areas in panels c and f are enlarged 2.5-fold in panels c' and f'. 
Arrows indicate the dendrites of type-II cholinergic amacrine cells that co-localize immunoreactivities for neurofilament and 
ChAT. The calibration bar (50 μm) in panel f applies to panels a-f, and the bar in i applies to panels g-i. Abbreviations: ChAT – 
choline acetyltransferase; INL – inner nuclear layer; IPL – inner plexiform layer; GCL – ganglion cell layer; NFL – nerve fiber 
layer.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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CRABP is transiently expressed by type-II cholinergic amacrine cells during embryonic development Figure 4
CRABP is transiently expressed by type-II cholinergic amacrine cells during embryonic development. Vertical sections of chick 
retina labeled with antibodies to CRABP (green) and ChAT (red). Sections were obtained from embryos at E6 (a-c), E7 (d-f), 
E8 (g-i), E11 (j-l), E16 (m-o), E18 (p-r) or from a postnatal chick (P3; s-u). Arrows indicate the IPL strata that are occupied by 
the dendrites of type-II cholinergic amacrine cells, and arrow-heads indicate representative cells that are immunoreactive for 
ChAT and CRABP. The calibration bar (50 μm) in panel l applies to panels a-l, the bar in r applies to p-r, and the bar in u 
applies to to m-o and s-r. The insets in panels o and u are high-magnification confocal images of the inner plexiform layer 
where the dendrites or the type-II cells terminate. Abbreviations: CRABP – cellular retinoic acid binding protein; ChAT – 
choline acetyltransferase; INL – inner nuclear layer; IPL – inner plexiform layer; GCL – ganglion cell layer.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
Page 8 of 17
(page number not for citation purposes)
In vitro conditions and muscarinic signaling influence the ratio of type-I to type-II cholinergic amacrine cells Figure 5
In vitro conditions and muscarinic signaling influence the ratio of type-I to type-II cholinergic amacrine cells. E7 retinas were dis-
sociated, plated and grown in culture for 24 hours. After 24 hours the cells were added with atropine (1, 10 or 50 μM), carba-
chol (1, 10 or 50 μM), or saline as a control, and maintained in culture for an additional 48 hours. Cells were labeled with 
antibodies to CRABP (red) and ChAT (green). Arrows (a-c) indicate type-II cholinergic cells that are immunoreactive for 
ChAT and CRABP, and arrow-heads indicate type-I cholinergic cells that are immunoreactive for ChAT alone. Cholinergic cells 
(arrows, d and e) did not accumulate BrdU after 3 DIV. The calibration bar (50 μm) in panel c applies to a-c and in e applies 
to d and e. Panel f shows the percentage of cholinergic cells also positive for CRABP (type-II cells). Asterisks indicate p-values 
< 0.05. Abbreviations: CRABP – cellular retinoic acid binding protein; ChAT – choline acetyltransferase; BrdU – Bromodeoxy-
uridine.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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(50,000 to 200,000 cells/cm2; data not shown). Prada and
colleagues [25] showed that cholinergic cells are postmi-
totic by about E4. To exclude the possibility of de novo
generation of cholinergic cells in culture, we cultured E7
retina in the presence of BrdU (to label newly generated
cells) for 3 days. None (n = 131) of the ChAT-positive cells
in cultures of E7 retina accumulated BrdU (Figs. 5d–e),
indicating that de novo generation of cholinergic amacrine
cells does not occur under culture conditions. Taken
together, these findings suggest that the environment pro-
vided by the intact retina is required to maintain equal
numbers of type-I and type-II cholinergic cells.
Since the type-II cholinergic cells are in close proximity
(<15 µm) to developing ganglion cells, whereas the type-
I cells are further away (>30 µm), it is possible that signals
provided by the differentiating ganglion cells influence
the development and phenotype of the type-II cells. Gan-
glion cells are known to produce Sonic Hedgehog (Shh)
as they differentiate [40,41] and Shh is known to establish
morphogenic gradients over short distances [42,43]. Thus,
it is possible that Shh stimulates type-II cholinergic ama-
crine cells to transiently express elevated levels of CRABP
during embryonic development. However, the relative
abundance of type-II cells was not significantly affected by
the addition of Shh or the blockade of Shh-signaling with
KAAD (3-keto, N-amino-ethyl aminocaproyl dihydrocin-
namoyl) cyclopamine. Shh-treated samples contained
3.1% (± 10.8%; 151 cells) more type-II cells, and cultures
treated with KAAD-cyclopamine contained 6.7% (± 5.7%;
140 cells) fewer type-II cells compared to control prepara-
tions. Statistical analyses indicated that these changes
were not significant.
There is some evidence that type-II cholinergic amacrine
cells express muscarinic receptors in the postnatal retina
[44]. In addition, antibodies to the m2 and m4 isoforms
of the muscarinic receptor in the embryonic chick retina
appear to label type-II-like cells in the developing IPL
[45,46]. Thus, it is possible that the type-II cholinergic
amacrine cells communicate to each other through para-
crine muscarinic interactions. To test this hypothesis we
applied a muscarinic antagonist (atropine) or agonist
(carbachol) to cultures of E7 retinas. We found that acti-
vation and suppression of muscarinic signaling reduced
the relative abundance of type-II cholinergic amacrine
cells (Fig. 5f).
Since the relative abundance of type-II to type-I choliner-
gic amacrine cells is reduced by in vitro conditions and by
influencing muscarinic signaling, we sought to assess
whether similar mechanisms influence the phenotype of
cholinergic cells in the intact retina. To test this, we made
intraocular injections of 300 ng of atropine (a muscarin-
inc antagonist) or 200 ng carbachol (a muscarinic ago-
nist) into the vitreous chamber of E7 chick embryos. The
E7 eye was estimated to have 75 mm3 of volume, which
should have resulted in initial maximum vitreal concen-
trations of carbachol and atropine of about 25 µM. Atro-
pine and carbachol have been used from 15 nM to 100
mM to elicit effects on retinal cells and chick muscarinic
acetylcholine receptors (mAChR) [47-49].
Similar to the findings of the in vitro studies, we found that
the number of cells that express ChAT and CRABP (type-
II-like cells) was decreased by muscarinic ligands. Treat-
ment with carbachol or atropine reduced the number of
ChAT-positive cells that are immunoreactive for CRABP in
the presumptive IPL (ANOVA, p = 0.017). There was a
reduction in the relative abundance of ChAT/CRABP-pos-
itive cells by about 23% with atropine treatment (n = 6, p
= 0.021) or by about 38% with carbachol treatment (n =
4, p = 0.018) (Fig. 6g). The abundance of type-II-like cells
in the IPL was not significantly different between treat-
ments with atropine or carbachol. We consistently found
that the type-I cells in the INL did not express detectable
levels of CRABP in retinas that were treated with mus-
carinic ligands. These findings suggest that gains or losses
in muscarinic signaling decrease the relative abundance of
CRABP-expressing cells among the type-II cholinergic
amacrine cells in vivo.
In addition to a decrease in the percentage of type-II
cholinergic amacrine cells, we found that the density of
ChAT-positive cells was decreased by treatment with both
a muscarinic AChR antagonist and agonist (ANOVA p =
0.0013, GCL; p = 0.0004, INL; Fig 6h). The number of
ChAT+ cells per 10,000 µm2 in the INL (type-I cells) and
in the GCL (type-II cells) was significantly decreased by
intraocular injections of atropine (p = 0.024, INL; p =
0.035, GCL; n = 6). Similarly, treatment with the mus-
carinic agonist carbachol decreased the density of cholin-
ergic amacrine cells in the INL and GCL (p = 0.0011, INL;
p = 0.002, GCL; n = 4). Decreases in the density of cholin-
ergic cells were not caused by increased apoptosis; we
failed to find increased numbers of cleaved caspase3-pos-
itive cells in retinas treated with atropine or carbachol
(Figs. 6i–k). Additionally, the muscarinic ligands did not
have any obvious effect on non-cholinergic neurons; gan-
glion cells labeled for Brn3a and horizontal, bipolar, ama-
crine and ganglion cells labeled for calretinin displayed
normal distributions when treated with atropine or carba-
chol (Figs. 6l and 6m).
In retinas treated with atropine or carbachol, we found
that the regularly patterned mosaic of cholinergic ama-
crine cells was disrupted (Figs. 7a–e). By visual inspection,
the type-I and type-II cells in retinas treated with atropine
or carbachol appeared irregularly spaced compared to
saline-treated retinas (Figs. 7a and 7b). To quantifyBMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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Muscarinic signaling influences the phenotype and density of cholinergic amacrine cells in the intact retina Figure 6
Muscarinic signaling influences the phenotype and density of cholinergic amacrine cells in the intact retina. Confocal micros-
copy was used to obtain optical sections of flat-mounted retinas labeled with antibodies to ChAT (green) and CRABP (red). 
Optical sections were obtained at the level of the developing IPL to visualize the type-II cells. Images are shown from retinas 
treated with saline (a-c) or atropine (d-f). The arrows indicate type-II cells that are immunoreactive for ChAT and CRABP, 
and the arrow-heads indicate cells that are immunoreactive for ChAT alone. Panel g is a histogram of the percentage of type-II 
cholinergic cells in the IPL that are immunoreactive for CRABP. Cells were counted from retinas that were treated with saline, 
atropine or carbachol. Panel h is a histogram of the number of ChAT-immunoreactive cells in the INL (type-I) and presumptive 
IPL (type-II) in retinas treated with saline, atropine or carbachol. The significance of difference was assayed by using ANOVA (p 
< 0.02) and a post-hoc Student's t-test (2 tailed, equal variance; *p < 0.05, **p < 0.025, ***p < 0.002). Panels i-m are represent-
ative microgrographs of retinal sections labeled for cleaved caspase 3 (green; i-k) and Islet1 (red; i) or CRABP (red; j and k), 
Brn3a (l), and calretinin (m). The calibration bar (50 μm) in panel f applies to panels a-f, the bar (50 μm) in i applies to i alone, 
the bar (10 μm) in k applies to j and k, and the bar (50 μm) in m applies to l and m. Abbreviations: INL – inner nuclear layer, 
IPL – inner plexiform layer, ChAT – choline acetyltransferase, CRABP – cellular retinoic acid binding protein.BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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Stimulation and inhibition of muscarinic signaling disrupts the patterning of cholinergic amacrine cells Figure 7
Stimulation and inhibition of muscarinic signaling disrupts the patterning of cholinergic amacrine cells. Panels a and b are repre-
sentative fields of view from the GCL of retinas treated with saline (a) or atropine (b). Whole-mount preparations of the ret-
ina were labeled with antibodies to ChAT and images were obtained by using confocal microscopy. The calibration bar (50 μm) 
in panel b applies to panels a and b. Panels c-e are dot-plots that were obtained by marking the center of individual cholinergic 
cells in the GCL of retinas treated with saline (c), atropine (d) or carbachol (e). Panel f is a histrogram of the mean regularity 
indices measured from cells of 3 different retinas that were treated with saline, atropine or carbachol. The significance of differ-
ence was assayed by using ANOVA (p = 0.0017) and a post-hoc Student's t-test (2 tailed, equal variance; *p = 0.00016, **p < 
0.0013).BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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whether the mosaic patterning of the cholinergic cells was
disrupted by the muscarinic ligands, we performed a near-
est neighbor analysis. Nearest neighbor regularity indices
with values above 7 are considered to be regular and val-
ues below 4 represent a random distribution. In saline-
treated retinas the regularity index of the cholinergic ama-
crine cells was high, with a value of 8.04 ± 0.68 (Fig. 7f).
The regularity index of the cholinergic cells was signifi-
cantly decreased in retinas treated with atropine (3.31, p
= 0.0002) or carbachol (5.02, p = 0.0013) compared to
the regularity index of the cholinergic cells in saline-
treated retinas (Fig. 7f). These findings suggest that pertur-
bation of muscarinic signaling disrupted the mosaic pat-
terning of the cholinergic amacrine cells.
Discussion
The genes that are expressed by differentiating cholinergic
amacrine cells are distinctly different from those that are
expressed by other types of amacrine cells. Unlike other
types of amacrine cells, the cholinergic cells express Islet1
with the onset of differentiation and into the mature ret-
ina, consistent with reports in the embryonic rat retina
[28]. As the cholinergic amacrine cells differentiate they
express proteins common to other types of amacrine cells
such as Pax6, CRABP and p27kip1. However, the relative
levels of immunolabeling for these proteins within the
cholinergic cells are either decreased (Pax6) or increased
(CRABP and p27kip1) compared to levels seen in other
types of differentiating amacrine cells. It is likely that
Islet1 and Pax6 play important roles in the development
and maintenance of phenotype of the type-I and type-II
cholinergic amacrine cells. The significance of elevated
expression of p27kip1 and CRABP in the cholinergic cells
remains unknown.
The type-I and type-II cholinergic amacrine cells are
equally abundant, morphologically identical, and are
arranged with near-mirror symmetry across a horizontal
plane through the IPL [18,19]. In addition to using acetyl-
choline, type-I and type-II cholinergic amacrine cells are
known to utilize GABA as a neurotransmitter [50,51] and
begin to accumulate GABA soon after they begin to differ-
entiate [25]. Furthermore, type-I and type-II cholinergic
amacrine cells in the chick retina have been shown to orig-
inate from a common pool of migrating, post-mitotic
undifferentiated neurons [25]. These findings have lead to
the assumption that these cells are phenotypically identi-
cal and differ only by the position of their somata. How-
ever, we provide evidence that these two cell types differ
by more than the location of their cell bodies. We found
that during differentiation, type-II cells transiently
expressed high levels of CRABP and neurofilament,
whereas the type-I cells do not. Further, in the postnatal
chick retina, type-II cells may express mAChR4, whereas
type-I cells do not [44,52], and these cells have different
sensitivities to excitotoxins, suggesting that different types
of glutamate receptors are expressed by these cells, and/or
that they have different susceptibilities to large fluctua-
tions in ion concentrations [4]. Embryonic expression of
mAChR2, mAChR3, and mAChR4 appear in non-overlap-
ping laminae of the developing IPL at E9 [52], suggesting
that these receptors may be expressed by different types of
amacrine cells. The mAChR1 may not exist in the chick
and [53] the retinal expression of mAChR5 [54] remains
uncertain, but has been detected in the sclera of Guinea
pigs [55,56] and human [57]. Differential expression of
receptor isoforms is a possible mechanism to explain the
differing effects of muscarinic ligands on the type-I and
type-II cholinergic cells.
The cholinergic cells may be among the first types of ama-
crine cell to differentiate, with the onset of ChAT and
Islet1 expression occurring while these cells are inter-
spersed among the developing ganglion cells at E6. By
comparison, amacrine cells that utilize different neuro-
transmitters such as dopamine, glucagon, enkephalin or
vasoactive intestinal peptide differentiate 6–9 days after
the cholinergic cells [58]. As development proceeds, the
Islet1/ChAT-positive cells migrate away from the ganglion
cells into the presumptive IPL where they begin to differ-
entiate. When the type-I and type-II cholinergic cells
become segregated into different laminae, the type-II cells
begin to express elevated levels of CRABP and neurofila-
ment. The close proximity of type-II cells to developing
ganglion cells may expose these cells to environmental
cues that influence the differentiation of ganglion cells.
Accordingly, this microenvironment may promote the
expression of genes common to both ganglion and type-II
cells (including Pax6, Islet1 and neurofilament). Secreted
signals produced by ganglion cells that influence the type-
II cholinergic cells could include Shh [40,41] and BMP2/
7 [59]. However, we failed to find evidence that Shh influ-
ences the differentiation of type-II cholinergic cells.
We found that the 1:1 ratio of type-I to type-II cholinergic
cells from the intact retina was disrupted when the cells
were dissociated and grown in culture; type-I cells were
twice as abundant as the type-II cells in vitro. In our in vitro
paradigm, it is likely that CRABP expression is down-reg-
ulated by the type-II cells making them indistinguishable
from the type-I cells. The disruption of the in vivo micro-
environment did not favor the differentiation of type-II
cholinergic cells – the co-expression of ChAT and CRABP.
These findings suggest that the factors promoting the type-
II phenotype are diluted under culture conditions and
that the phenotype of type-II cells relies, in part, on the
microenvironment provided by the intact retina. Alterna-
tively, the survival of type-II cholinergic amacrine cells
may be selectively compromised by acute dissociation
and culture conditions (i.e. serum). It is unlikely thatBMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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changes in the relative abundance of type-I to type-II
cholinergic cells resulted from cell fate decisions made
during the terminal mitosis. We did not find any cholin-
ergic cells in our in vitro and in vivo paradigms that were
labeled for BrdU, indicating that none of the cholinergic
cells were generated after the cultures were established or
after compounds were delivered to the developing eye.
Similar to the results of our in vitro studies, we found that
the in vivo development of the cholinergic amacrine cells
was influenced by muscarinic ligands. In saline-treated
retinas, the vast majority of cholinergic cells in the GCL
express CRABP. However, treatment with muscarinic lig-
ands resulted in increased numbers of type-II cells that
failed to express CRABP. These findings suggest that
appropriate levels of muscarinic signaling are required for
the maintenance of CRABP expression in the type-II cells;
perturbation of optimal levels of muscarinic signaling
between cholinergic cells by agonist or antagonist dis-
rupted the phenotype of these cells. It remains uncertain
whether the effects of the muscarinic ligands were medi-
ated by direct or indirect actions on the type-II cells. The
patterning of the cholinergic amacrine cells is likely coor-
dinated by several distinct signaling pathways in addition
to the muscarinic pathway. For example, extra-cellular
ATP and the P2X receptor influence the patterning and
survival of the cholinergic cells in the rodent retina [26].
In addition, Zhang and colleagues [60] have shown that
maintenance of array of type-II amacrine cells in the
mouse GCL is dependent upon visual activity; after 30
days of rearing pups in the dark, ChAT-positive cells are
undetectable in the GCL, but remain present in the INL.
Inhibiting mAChRs with atropine or activating mAChRs
with carbachol disrupted the regular spacing between the
cholinergic amacrine cells. We propose that the proper
patterning of the cholinergic cells requires optimal levels
of muscarinic signaling similar to the Shh concentration-
dependent differentiation of spinal cord interneurons
[61]. In principle, release and diffusion of ACh from a
cholinergic cell should result in a concentration gradient
that decreases with increasing distance from the source.
Regular spacing between cells can occur if like-cells are
repelled from each other; and for the cholinergic amacrine
cells this may involve migrating laterally away from
neighboring, concentrated sources of ACh. Our data are
consistent with the hypothesis that the regular spacing of
the cholinergic cells requires an optimal level of mus-
carinic signaling, and if these cells encounter gains or
losses in signaling the mosaic patterning is disrupted.
It remains uncertain what effect perturbations in mus-
carinic signaling have on the spontaneous calcium waves,
spread through the cholinergic amacrine cells, that are
necessary for the establishment of early retinal circuitry in
the IPL [27,62]. The mosaic pattern of the cholinergic cells
may, in part, be required to establish normal waves of
activity. However, this activity was shown to be regulated
by nicotinic AChR in the embryonic retina [27,63]. It is
possible that the application of muscarinic compounds
generally perturbed retinal development and thereby dis-
rupted the patterning of the cholinergic cells. However,
we found that muscarinic compounds did not affect non-
cholinergic cells expressing calretinin, Islet1 or Brn3a-pos-
itive ganglion cells, and we failed to observe an increase in
immunolabeling for cleaved-caspase 3. Taken together,
these findings indicate muscarinic ligands do not overtly
affect non-cholinergic inner retinal neurons.
The type-I and type-II cells are not likely to influence each
other through cholinergic signaling across the developing
IPL. For example, the mosaic pattern of type-II cholinergic
amacrine cells in the GCL has no relation to the pattern of
type-I cells in the INL [24]. Additionally, acetylcholine
esterase (AChE) is first detected in the chick retina
between E7 and E9 in the middle of the IPL when the dif-
ferentiating cholinergic cells are segregating between the
GCL and INL [48,64]. AChE that is distributed into dis-
crete laminae in the IPL should prevent any vertical diffu-
sion of ACh through the retina. For example, ACh released
from the type-II cells is not likely to act on type-I cells
because AChE in the IPL is stratified between the den-
drites of these cells and should degrade the ACh that dif-
fuses distally through the IPL. However, given the dense
intermingling of the dendrites of the cholinergic cells
within narrow strata of the IPL, it seems likely that ACh
released from the dendrites of one cholinergic cell could
act on a neighboring cell with overlapping, co-stratified
dendritic arbors.
It is possible that decreases in the density of cholinergic
cells resulted from increases in cell death. However, we
failed to detect increased numbers of cleaved-caspase 3
positive cells in retinas treated with carbachol or atropine.
We cannot exclude the possibility that the death of cholin-
ergic cells occurred in a caspase 3-independent manner
resulting in reduced numbers of cholinergic cells and per-
haps disruption of the mosaic patterning. Another possi-
bility is that decreases in the abundance of ChAT/CRABP-
positive cells in the IPL resulted from the down-regulation
of ChAT and CRABP. Consistent with this hypothesis,
ChAT may be transiently expressed by some cells in the
GCL similar to the developing turtle retina, indicating that
ChAT expression may be reversible in some types of reti-
nal cells [65].
The large diversity of amacrine cell types that are distrib-
uted in mosaic patterns with regular spacing implies that
autologous signals are required to coordinate the pattern-
ing of unique cell types. The notion of homotypic interac-BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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tions underlying mosaic patterning has been proposed for
the cholinergic amacrine cells in the retina [65]. Further-
more, Rossi and colleagues [66] demonstrated that the
establishment of regular spacing between horizontal cells
in the rodent retina occurs independent of pre-synaptic
input from photoreceptors, suggesting that patterning is
mediated via homotypic interactions among the horizon-
tal cells. It is possible that homotypic interactions are
responsible for the regular spacing of the different types of
horizontal, amacrine and ganglion cells. Consistent with
this hypothesis, cones, horizontal cells, ganglion cells,
and cholinergic amacrine cells migrate laterally away from
their radial column of clonally derived cells, whereas
bipolar cells and Müller glia do not [67]. To establish a
highly ordered mosaic pattern, cells within the retina
must have the ability to migrate laterally away from col-
umns of clonally derived cells unless the order of the array
is determined by the progenitors. A likely mechanism
underlying the spatial patterning between like-cells is the
use of peptide or amino acid-derived transmitters to pro-
vide homotypic signals between cells. For example,
dopamine, glucagon, neuropeptide Y, substance P,
vasoactive intestinal polypeptide or enkephalin, neuro-
transmitters that are used by distinct types of amacrine
cells, are used as autologous signals to coordinate cell
type-specific patterning. Consistent with this hypothesis,
our data indicate that the disruption of muscarinic ACh
signaling perturbs the numbers, spacing and phenotype of
cholinergic amacrine cells in the developing retina.
Conclusion
We conclude that, during development, type-II choliner-
gic amacrine cells transiently express CRABP and neurofil-
ament, while type-I cells do not. We propose that the
transient expression of CRABP and neurofilament is regu-
lated by local microenvironment. Additionally, we find
that interfering with muscarinic signaling decreases the
relative number of type-II cells and mosaic patterning of
the cholinergic amacrine cells. We propose that the phe-
notypic differences between developing type-I and type-II
cholinergic amacrine cells are elicited, in part, by para-
crine cholinergic signaling; the local microenvironment of
the in tact retina allows precise muscarinic signaling to
establish proper cellular phenotypes and organization of
the type-II cells. It remains uncertain whether muscarinic




The use of animals in these experiments was in accordance
with the guidelines established by the National Institutes
of Health and the Ohio State University. Eggs were
obtained from the Department of Animal Sciences at the
Ohio State University. Chick embryos were staged accord-
ing to guidelines established by Hamburger and Hamil-
ton [68]. Newly hatched leghorn chickens (Gallus gallus
domesticus) were obtained from the Department of Animal
Sciences at the Ohio State University and kept on a cycle
of 12 hours light, 12 hours dark (lights on at 7:00 am).
Chicks were housed in a stainless steel brooder at about
27°C and received water and Purina™ chick starter ad libi-
tum.
Cell Culture
Embryonic chick retinas were dissected in sterile Hanks'
buffered saline solution added with 3% D-glucose and
0.01 M HEPES buffer (HBSS+). Retinal cells were dissoci-
ated by mild trituration after a 10-minute incubation at
37°C in Ca2+/Mg2+-free HBSS plus 0.025% trypsin. Cell
density was determined by using a hemocytometer.
Between 50,000 and 200,000 cells were added to wells of
a 24-well plate coated with poly-D-lysine (Sigma). Cell
cultures were maintained at 37°C in 5% CO2 under cul-
ture medium (DMEM:F12 without glutamate or aspartate,
plus 100 units/ml penicillin, 100 mg/ml streptomycin,
0.05 M HEPES; Sigma, and 1% fetal bovine serum; Invit-
rogen). Cultures were maintained for 1 to 4 days with
50% of the medium replaced every 24 hours. After one
day in vitro, retinal cells were added with 20 ng/ml Sonic
Hedgehog (rmShh-N; R & D Systems), or 40 ng/ml KAAD
(3-Keto-N-amino ethyl amino caproyldihydrocinnamoyl
Cyclopamine; Toronto Research Chemicals), 1, 10 or 50
µM of atropine (Sigma) or 1, 10 or 50 µM of carbachol
(Sigma). Additional cultures were maintained for 3 DIV in
the presence of 1 µg/ml Bromodeoxyuridine (BrdU). Cells
were fixed and processed for immunocytochemistry at 1
or 3 days after the addition of Shh, cyclopamine, atropine,
or carbachol.
In ovo injections
Time-staged eggs at E6 were windowed and access to the
eye obtained by carefully tearing the chorioallantois and
amniotic membranes around the embryo. The stage of the
embryo was verified at this time according to the guide-
lines established by Hamburger and Hamilton (1951). A
40 gauge wire was used to pierce the dorsal side of the
right eye. A pulled capillary pipette was then used to
deliver 2 µl of a solution that contained 1 mM (200 ng)
carbachol, 1 mM atropine (300 ng), or sterile saline solu-
tion (control) added with 0.4% fast green in glycerol
water (1:1) and 3 µg BrdU. The chorionic membranes
were placed back over the embryo, the window sealed
with transparent tape, and the egg placed back into the
incubator. Embryos were sacrificed 24 hours later and the
injected eye enucleated. The anterior portion of the eye
and vitreous were removed and discarded prior to fixa-
tion. After fixation, the ventral portion of the retina was
removed and labeled for BrdU to verify the efficacy of the
injection and to verify that the injection was made afterBMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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terminal mitosis of the cells fated to differentiate as
cholinergic amacrine cells. Retinas that labeled for BrdU
in the GCL or presumptive IPL were discarded from the
experiments. The remaining retina was processed for
whole-mount immunolabeling.
Fixation and sectioning
Eyes were enucleated, the anterior portion of the eye dis-
sected away, and the vitreous removed. Eyes or dissociated
cells were fixed for 30 minutes at 20°C in 4% paraformal-
dehyde plus 3% sucrose in 0.1 M phosphate buffer, pH
7.4. Fixation was followed by 3 washes in PBS (phos-
phate-buffered saline; 0.05 M phosphate buffer, 195 mM
NaCl, pH 7.4). Eye-cups were cryoprotected in PBS plus
30% sucrose, soaked in embedding medium (O.C.T.-
compound; Tissue-Tek) for 30 minutes, and freeze-
mounted onto aluminum sectioning blocks. Transverse
sections nominally 12 µm thick were cut consistently
from the posterior pole of the eye, near the dorsal portion
of the ventral fissure (or pecten in postnatal eyes), and
thaw-mounted onto SuperFrost Plus™ slides (Fisher Scien-
tific). Sections were air-dried and stored at -20°C.
Immunocytochemistry
Sections were washed 3 times in PBS, covered with pri-
mary antibody solution (Table 1; 150 µl of antiserum
diluted in PBS plus 5% normal goat serum, and 0.2% Tri-
ton X-100), and incubated for about 24 hours at 20°C in
a humidified chamber. The slides were washed 3 times in
PBS, covered with secondary antibody solution (150 µl of
1:1000 Alexafluor-conjugated secondary antibodies, Inv-
itrogen), and incubated for about 1 hour at 20°C in a
humidified chamber. Finally, samples were washed 3
times in PBS and coverslip mounted with 4:1 (v/v) glyc-
erol to water for observation under an epifluorescence
microscope. When double labeling with BrdU, the com-
plimentary label was fixed after the secondary antibody
then acid treat before addition of the primary antibody to
BrdU as described previously [69]. To permeablize retinas
for whole-mount labeling procedures, samples were fro-
zen (-80°C) and thawed (20°C) three times prior to incu-
bation with the antibody solution. Both primary and
secondary antibodies were incubated over night. We eval-
uated antibody specificity mainly by comparison with the
results of previous studies using these antibodies and,
where possible, by known homologies between the
immunizing proteins and the chick counterparts.
Photography, measurements, cell counts, and statistical 
analyses
Photomicrographs were taken by using a Leica DM5000B
microscope equipped with epifluorescence and a Leica
DC500 digital camera. Confocal microscopy was done by
using a Zeiss LSM 510 meta at the Campus Microscopy
and Imaging Facility at Ohio State University. Confocal
stacks of images were obtained for 1 µm-thick optical sec-
tions by using a 20× objective (0.75 NA) and multi-track,
narrow-pass emission filter settings to exclude the possi-
bility of fluorescence bleeding across channels. Images
were optimized for color, brightness and contrast, and
double-labeled images overlaid by using Adobe Pho-
toshop™6.0. To avoid the possibility of region-specific dif-
ferences within the retina, cell counts were consistently
made from the same region of retina for each data set. Sig-
nificance of difference among data sets was determined by
using ANOVA. Data from treated and control eyes were
compared statistically with the appropriate post-hoc Stu-
dent's t-test.
Cell counts from cultured cells were performed on at least
100 cells from each coverslip per condition (n ? 5;
untreated, Shh, KAAD, atropine and carbachol). Experi-
ments were repeated three times. For whole mount
images, one optical slice from a confocal z-series was
selected for the INL and one for the GCL per individual.
These slices were overlaid in Adobe Photoshop 6.0 and
Table 1: Antigen, species, immunogen, working dilution, and source of the antibodies used in the current study.
Antigen Species Clone/catalogue#/Supplier Working dilution
AP2? mouse 3B5/Developmental Studies Hybridoma Bank 1:50
Bromdeoxyuridine (BrdU) rat BUI/75/Accurate Chemicals and Scientific Corporation 1:400
Brn3a mouse MAB1585/Chemicon 1:1500
Choline acetyltransferase (ChAT) rabbit 1456/Dr. Miles Epstein, University of Wisconsin 1:1500
Calretinin Rabbit 7699/4/SWANT 1:1000
Cellular Retinoic Acid Binding Protein (CRABP) 
(CRABP)
mouse C1/Dr. Jack Saari, University of Washington 1:1000
Islet1 mouse 40.2D6/Developmental Studies Hybridoma Bank 1:50
Neurofilament (NF) (160 kDa) mouse RMO270/Dr. V. Lee, University of Pennsylvania 1:2000
p27kip1 mouse Clone 57/Transduction Laboratories 1:200
Pax6 mouse PAX6/Developmental Studies Hybridoma Bank 1:50
Prox1 rabbit Dr. Stanislov Tomarev, NIH 1:800BMC Developmental Biology 2008, 8:13 http://www.biomedcentral.com/1471-213X/8/13
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five 200 µm2 fields per retina were counted. At least four
individual retinae and at least 600 cells per retina were
counted per condition. As described elsewhere [70,71], an
index of regularity was calculated as the mean distance to
the nearest neighbor divided by the standard deviation.
The distance between cells was measured from confocal
micrographs and was taken as the distance from the center
of one cell to the center of the next nearest cell. Measure-
ments were made from ten randomly selected cells per
field of view for three individual retinas per condition (90
cells total). Data is presented as the mean and standard
deviation.
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